Governance: An international journal of policy, administration and institutions

How worries about reputation shape FDA enforcement

Public agencies care about their reputations.  In the current issue of Governance, Moshe Maor and Raanan Sulitzeanu-Kenan of the Hebrew University of Jerusalem explore how “the vague concept of reputation may translate into concrete regulatory outcomes.”  They examine the behavior of two enforcement divisions within the U.S. Food and Drug Administration.  As media coverage of the FDA becomes more positive, the agency takes longer to execute enforcement actions.  Negative coverage leads to quicker action.  This is only true, though, when press coverage is relatively intense.  “Reputational concerns,” conclude  Moar and Sulitzeanu-Kenan, “produce institutional outcomes over and above the content of rules, guidance, procedures, structures or statutes.”   FREE ACCESS to this article.

Written by governancejournal

January 16, 2013 at 4:55 pm

Posted in Current issue


Get every new post delivered to your Inbox.

Join 74 other followers

Powered by
%d bloggers like this: